In contrast, at baseline FSTL1 production seemed already exhausted in patients with end-stage pulmonary fibrosis developing PGD but could still be temporarily increased by the intraoperative inflammatory response. This evidence concerns the gene FSTL1 and pulmonary fibrosis.